The goal of this program is to improve patient outcomes through understanding of obstructive sleep apnea (OSA) and Alzheimer disease (AD). After hearing and assimilating this program, the clinician will be better able to:Explain the effects of dual orexin receptor antagonists on cerebrospinal fluid levels in patients with low sleep efficiency.Assess the effects of continuous positive airway pressure therapy on cognitive decline in patients with AD and OSA.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Otolaryngology
- Start Date: 2024-10-01 05:00:00
- End Date: 2024-10-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- MOC Credit Details: ABOHNS - 0.75 Point; Credit Type(s): Self-Assessment (ABOHNS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Sleep Medicine
Subscribe
Login
0 Comments
Oldest